60
Participants
Start Date
April 28, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Low Dose Naltrexone
Participants will start with 3mg LDN orally administered daily for one week, with a planned increase to 4 mg/day beginning week two, if tolerated. They will be provided with a 4-week supply of study medication. The most common side effects are difficulty sleeping and vivid dreams, which are seen more frequently with nighttime dosing, so LDN will be given as a daytime dose.
RECRUITING
Grady Memorial Hospital, Atlanta
RECRUITING
Emory Midtown Hospital, Atlanta
RECRUITING
Emory University Hospital, Atlanta
Emory University
OTHER